Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | METAP2 | P50579 | 4/20 | 0.43 |
| ▸ | GFER | P55789 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27778339 | 0.98 | MEN1 (0.44) | MEN1KMT2ATAAR1LMNAHSD17B10 | |
| SCHEMBL9203352 | 0.78 | MEN1 (0.50) | MEN1KMT2ALMNAMAPTGAA | |
| SCHEMBL1239469 | 0.77 | — | — | |
| SCHEMBL13715672 | 0.74 | SMN1; SMN2 (0.57) | MEN1KMT2ATAAR1MAPTTSHR | |
| SCHEMBL5185274 | 0.74 | — | — | |
| SCHEMBL5369831 | 0.73 | KMT2A (0.46) | MEN1KMT2ALMNAMAPTMETAP2 | |
| SCHEMBL8824766 | 0.72 | ROCK1 (0.50) | MEN1KMT2ALMNAMAPTGAA | |
| Biphenyl SCHEMBL28349298 | 0.72 | XDH (0.40) | ALDH1A1TDP1TSHRMAPK1L3MBTL1 | |
| SCHEMBL6632277 | 0.71 | SMN1; SMN2 (0.49) | MEN1KMT2ALMNAHSD17B10GAA | |
| SCHEMBL11293292 | 0.71 | MAPT (0.30) | HSD17B10MAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3686207-B1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEM (JP) | 2024-10-23 | — | — | EP | claimed |
| CN-101248054-B | Thiazole derivatives and use thereof | MERCK SERONO SA | 2012-05-09 | — | — | CN | claimed |
| US-20070102076-A1 | Gas-producing mixtures | DELPHI TECHNOLOGIES, INC. (US) | 2007-05-10 | — | — | US | claimed |
| EP-0809616-A1 | GAS-GENERATING MIXTURES | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) | 1997-12-03 | — | — | EP | claimed |
| WO-1996026169-A1 | GAS-GENERATING MIXTURES | DYNAMIT NOBEL GMBH (DE) | 1996-08-29 | — | — | WO | claimed |
| EP-4722199-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024247919-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | 四国化成工業株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2024-11-07 | — | — | US | disclosed |
| EP-3686207-B1 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEM (JP) | 2024-10-23 | — | — | EP | disclosed |
| CN-116183591-A | Gold nanoparticle for detecting cadmium ions and preparation method and application thereof | 宁波大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-111108111-B | Tetrazole silane compound, method for synthesizing the compound, and use thereof | 四国化成工业株式会社 | 2023-05-02 | — | — | CN | disclosed |
| US-11472823-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2022-10-18 | — | — | US | disclosed |
| EP-0809616-A1 | GAS-GENERATING MIXTURES | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) | 1997-12-03 | — | — | EP | disclosed |
| WO-1996026169-A1 | GAS-GENERATING MIXTURES | DYNAMIT NOBEL GMBH (DE) | 1996-08-29 | — | — | WO | disclosed |
| WO-1995014679-A1 | TETRAZOLE-SUBSTITUTED UREA ACAT INHIBITORS | PARKE, DAVIS & COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |
| EP-0413051-B1 | Benzothiazine-1,1-dioxide derivatives | NIPPON HYPOX LAB INC (JP) | 1995-03-15 | — | — | EP | disclosed |
| US-5362744-A | Treatnent of athrosclerosis, anticholesterol agents | WARNER-LAMBERT COMPANY (US) | 1994-11-08 | — | — | US | disclosed |
| EP-0519485-A1 | Propellant for gas generators | Dynamit Nobel Aktiengesellschaft (DE) | 1992-12-23 | — | — | EP | disclosed |
| US-5004742-A | Enzyme inhibitors | NIPPON HYPOX LABORATORIES INCORPORATED (JP) | 1991-04-02 | — | — | US | disclosed |
| EP-0413051-A1 | Benzothiazine-1,1-dioxide derivatives | NIPPON HYPOX LABORATORIES INCORPORATED (JP) | 1991-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472823-B2 | Tetrazole silane compound, method for synthesizing said compound and use thereof | TST, ITGA5, TPX2 | MEN1 2187/4885KMT2A 735/4885TAAR1 253/4885 |
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | NLRP3, NLRP1, NOD1 | MEN1 4618/4885KMT2A 4759/4885TAAR1 4287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.